Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine Manufactured With and Without Polysorbate 80 Given to Healthy Infants at 2, 3, 4 and 12 Months of Age - Concepedia

Concepedia

Publication | Closed Access

Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine Manufactured With and Without Polysorbate 80 Given to Healthy Infants at 2, 3, 4 and 12 Months of Age

10

Citations

15

References

2014

Year

Janusz Gadzinowski, S. Tansey, Jacek Wysocki, Elżbieta Kopińska, Ewa Majda-Stanisławska, Hanna Czajka, Piotr Korbal, Jacek J Pietrzyk, Sherryl Baker, Peter C. Giardina,

The Pediatric Infectious Disease Journal

Abstract

Addition of P80 to PCV13 did not adversely affect PCV13 immunogenicity or safety when compared with vaccine formulated without P80.

References

	Year	Citations

Page 1